Literature DB >> 26299579

MiR-126 Contributes to Human Umbilical Cord Blood Cell-Induced Neurorestorative Effects After Stroke in Type-2 Diabetic Mice.

Jieli Chen1,2, Ruizhuo Ning1, Alex Zacharek1, Chengcheng Cui1, Xu Cui1, Tao Yan1, Poornima Venkat1,3, Yi Zhang1, Michael Chopp1,3.   

Abstract

Diabetes mellitus (DM) is a high risk factor for stroke and leads to more severe vascular and white-matter injury than stroke in non-DM. We tested the neurorestorative effects of delayed human umbilical cord blood cell (HUCBC) treatment of stroke in type-2 diabetes (T2DM). db/db-T2DM and db/+-non-DM mice were subjected to distal middle cerebral artery occlusion (dMCAo) and were treated 3 days after dMCAo with: (a) non-DM + Phosphate buffered saline (PBS); (b) T2DM + PBS; (c) T2DM + naïve-HUCBC; (d) T2DM + miR-126(-/-) HUCBC. Functional evaluation, vascular and white-matter changes, neuroinflammation, and miR-126 effects were measured in vivo and in vitro. T2DM mice exhibited significantly decreased serum and brain tissue miR-126 expression compared with non-DM mice. T2DM + HUCBC mice exhibited increased miR-126 expression, increased tight junction protein expression, axon/myelin, vascular density, and M2-macrophage polarization. However, decreased blood-brain barrier leakage, brain hemorrhage, and miR-126 targeted gene vascular cell adhesion molecule-1 and monocyte chemotactic protein 1 expression in the ischemic brain as well as improved functional outcome were present in HUCBC-treated T2DM mice compared with control T2DM mice. MiR-126(-/-) HUCBC-treatment abolished the benefits of naïve-HUCBC-treatment in T2DM stroke mice. In vitro, knock-in of miR-126 in primary cultured brain endothelial cells (BECs) or treatment of BECs with naïve-HUCBCs significantly increased capillary-like tube formation, and increased axonal outgrowth in primary cultured cortical neurons; whereas treatment of BECs or cortical neurons with miR-126(-/-) HUCBC attenuated HUCBC-treatment-induced capillary tube formation and axonal outgrowth. Our data suggest delayed HUCBC-treatment of stroke increases vascular/white-matter remodeling and anti-inflammatory effects; MiR-126 may contribute to HUCBC-induced neurorestorative effects in T2DM mice.
© 2015 AlphaMed Press.

Entities:  

Keywords:  Human umbilical cord blood cell; Stroke; Type-2 diabetes; White matter; microRNA126

Mesh:

Substances:

Year:  2016        PMID: 26299579      PMCID: PMC4713352          DOI: 10.1002/stem.2193

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  60 in total

1.  A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes.

Authors:  Xiang Fan; Jianhua Qiu; Zhanyang Yu; Haibin Dai; Aneesh B Singhal; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2011-11-03       Impact factor: 7.914

2.  Axonal outgrowth and dendritic plasticity in the cortical peri-infarct area after experimental stroke.

Authors:  Yuji Ueno; Michael Chopp; Li Zhang; Benjamin Buller; Zhongwu Liu; Norman L Lehman; Xian Shuang Liu; Yi Zhang; Cynthia Roberts; Zheng Gang Zhang
Journal:  Stroke       Date:  2012-05-22       Impact factor: 7.914

3.  AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.

Authors:  Pavani Mocharla; Sylvie Briand; Giovanna Giannotti; Carola Dörries; Philipp Jakob; Francesco Paneni; Thomas Lüscher; Ulf Landmesser
Journal:  Blood       Date:  2012-11-08       Impact factor: 22.113

4.  IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal.

Authors:  Chongxiu Sun; Kenan Alkhoury; Ying I Wang; Greg A Foster; Christopher E Radecke; Kayan Tam; Christina M Edwards; Marc T Facciotti; Ehrin J Armstrong; Anne A Knowlton; John W Newman; Anthony G Passerini; Scott I Simon
Journal:  Circ Res       Date:  2012-08-08       Impact factor: 17.367

5.  Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1.

Authors:  S Meng; J-T Cao; B Zhang; Q Zhou; C-X Shen; C-Q Wang
Journal:  J Mol Cell Cardiol       Date:  2012-04-16       Impact factor: 5.000

Review 6.  MicroRNAs in immune response and macrophage polarization.

Authors:  Gang Liu; Edward Abraham
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

7.  Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.

Authors:  Feng Huang; Xiao Zhu; Xin-Qun Hu; Zhen-Fei Fang; Liang Tang; Xiao-Ling Lu; Sheng-Hua Zhou
Journal:  Int J Mol Med       Date:  2012-12-03       Impact factor: 4.101

8.  miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis.

Authors:  Yun Zhang; Pengyuan Yang; Tao Sun; Dong Li; Xin Xu; Yaocheng Rui; Chaoran Li; Mengyang Chong; Toni Ibrahim; Laura Mercatali; Dino Amadori; Xincheng Lu; Dong Xie; Qi-Jing Li; Xiao-Fan Wang
Journal:  Nat Cell Biol       Date:  2013-02-10       Impact factor: 28.824

9.  Adipose tissue microRNAs as regulators of CCL2 production in human obesity.

Authors:  Erik Arner; Niklas Mejhert; Agné Kulyté; Piotr J Balwierz; Mikhail Pachkov; Mireille Cormont; Silvia Lorente-Cebrián; Anna Ehrlund; Jurga Laurencikiene; Per Hedén; Karin Dahlman-Wright; Jean-François Tanti; Yoshihide Hayashizaki; Mikael Rydén; Ingrid Dahlman; Erik van Nimwegen; Carsten O Daub; Peter Arner
Journal:  Diabetes       Date:  2012-06-11       Impact factor: 9.337

10.  Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice.

Authors:  Roham Parsa; Pernilla Andresen; Alan Gillett; Sohel Mia; Xing-Mei Zhang; Sofia Mayans; Dan Holmberg; Robert A Harris
Journal:  Diabetes       Date:  2012-06-28       Impact factor: 9.461

View more
  31 in total

1.  MiR-126 Affects Brain-Heart Interaction after Cerebral Ischemic Stroke.

Authors:  Jieli Chen; Chengcheng Cui; Xiaoping Yang; Jiang Xu; Poornima Venkat; Alex Zacharek; Peng Yu; Michael Chopp
Journal:  Transl Stroke Res       Date:  2017-01-19       Impact factor: 6.829

2.  MiR-126 Mediates Brain Endothelial Cell Exosome Treatment-Induced Neurorestorative Effects After Stroke in Type 2 Diabetes Mellitus Mice.

Authors:  Poornima Venkat; Chengcheng Cui; Michael Chopp; Alex Zacharek; Fengjie Wang; Julie Landschoot-Ward; Yi Shen; Jieli Chen
Journal:  Stroke       Date:  2019-08-09       Impact factor: 7.914

3.  Neurorestorative Responses to Delayed Human Mesenchymal Stromal Cells Treatment of Stroke in Type 2 Diabetic Rats.

Authors:  Tao Yan; Poornima Venkat; Michael Chopp; Alex Zacharek; Ruizhuo Ning; Cynthia Roberts; Yi Zhang; Mei Lu; Jieli Chen
Journal:  Stroke       Date:  2016-10-11       Impact factor: 7.914

Review 4.  Transplantation of Exercise-Induced Extracellular Vesicles as a Promising Therapeutic Approach in Ischemic Stroke.

Authors:  Parsa Alehossein; Maryam Taheri; Pargol Tayefeh Ghahremani; Duaa Dakhlallah; Candice M Brown; Tauheed Ishrat; Sanaz Nasoohi
Journal:  Transl Stroke Res       Date:  2022-05-21       Impact factor: 6.829

5.  White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies.

Authors:  Poornima Venkat; Michael Chopp; Alex Zacharek; Chengcheng Cui; Li Zhang; Qingjiang Li; Mei Lu; Talan Zhang; Amy Liu; Jieli Chen
Journal:  Neurobiol Aging       Date:  2016-11-19       Impact factor: 4.673

6.  Role of microRNA-126 in vascular cognitive impairment in mice.

Authors:  Peng Yu; Poornima Venkat; Michael Chopp; Alex Zacharek; Yi Shen; Ruizhuo Ning; Linlin Liang; Wei Li; Li Zhang; Julie Landschoot-Ward; RongCai Jiang; Jieli Chen
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-14       Impact factor: 6.200

7.  Delayed rFGF21 Administration Improves Cerebrovascular Remodeling and White Matter Repair After Focal Stroke in Diabetic Mice.

Authors:  Yinghua Jiang; Jinrui Han; Yadan Li; Yinga Wu; Ning Liu; Samuel X Shi; Li Lin; Jing Yuan; Shusheng Wang; Ming-Ming Ning; Aaron S Dumont; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2021-09-15       Impact factor: 6.829

Review 8.  Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach.

Authors:  Andreia Gomes; Pedro Coelho; Raquel Soares; Raquel Costa
Journal:  Cell Tissue Res       Date:  2021-05-29       Impact factor: 5.249

9.  CD133+Exosome Treatment Improves Cardiac Function after Stroke in Type 2 Diabetic Mice.

Authors:  Poornima Venkat; Chengcheng Cui; Zhili Chen; Michael Chopp; Alex Zacharek; Julie Landschoot-Ward; Lauren Culmone; Xiao-Ping Yang; Jiang Xu; Jieli Chen
Journal:  Transl Stroke Res       Date:  2020-03-20       Impact factor: 6.829

Review 10.  Cell-based and pharmacological neurorestorative therapies for ischemic stroke.

Authors:  Poornima Venkat; Yi Shen; Michael Chopp; Jieli Chen
Journal:  Neuropharmacology       Date:  2017-09-01       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.